1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
ENvue Medical, Inc.

ENvue Medical, Inc.

FEED
ENvue Medical, Inc.US flagNASDAQ Global Market
0.37
USD
+0.02
- -
409,306.00Market Cap

Total Valuation

ENvue Medical, Inc. carries a market capitalization of 409,306.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap409,306.00
Enterprise Value2.30M

Share Statistics

ENvue Medical, Inc. currently has 3.70M shares outstanding.

Shares Outstanding3.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.53, and the price-to-book ratio stands at -0.03.

PE RatioN/A
PS Ratio1.53
PB Ratio-0.03
P/TBV Ratio-2.69
P/FCF Ratio-0.27
P/OCF Ratio-0.27

Enterprise Valuation

EV / Sales1.06
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

ENvue Medical, Inc. maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.78, indicating elevated leverage, while an interest coverage ratio of -53.64 demonstrates limited ability to service its debt obligations.

Current Ratio0.90
Quick Ratio0.43
Debt / Equity3.78
Debt / EBITDA-0.10
Interest Coverage-53.64

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-47.95
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)7.82
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.14

Taxes

Over the trailing twelve months, ENvue Medical, Inc. has paid -289,000.00 in income taxes, reflecting an effective tax rate of 6.42.

Income Tax-289,000.00
Effective Tax Rate6.42

Stock Price Statistics

ENvue Medical, Inc.'s stock has declined approximately -92.06823% over the past 52 weeks. The 50-day moving average sits at 4.00, while the 200-day moving average is 4.00.

Beta (5Y)N/A
52-Week Price Change-92.06823%
50-Day Moving Average4.00
200-Day Moving Average4.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, ENvue Medical, Inc. generated 2.18M in revenue and converted that into -20.13M in net income, yielding earnings per share of -14.40. EBITDA reached -12.50M, while operating income came in at -13.59M.

Revenue2.18M
Gross Profit-271,000.00
Operating Income-13.59M
Pretax Income-20.42M
Net Income-20.13M
EBITDA-12.50M
EBIT-13.59M
Earnings Per Share (EPS)-14.40

Balance Sheet

ENvue Medical, Inc. holds 2.24M in cash and equivalents against 1.21M in total debt, resulting in a net debt position of -1.15M. Total book value stands at -112.13M, with working capital of -668,000.00 providing operational flexibility.

Cash & Cash Equivalents2.24M
Total Debt1.21M
Net Debt-1.15M
Equity (Book Value)-112.13M
Book Value Per Share-80.17
Working Capital-668,000.00

Cash Flow

ENvue Medical, Inc. produced -12.34M in operating cash flow over the past twelve months. After subtracting -72,000.00 in capital expenditures, free cash flow totaled -12.41M - equivalent to -8.88 per share.

Operating Cash Flow-12.34M
Capital Expenditures-72,000.00
Free Cash Flow-12.41M
FCF Per Share-8.88

Margins

ENvue Medical, Inc. operates with a gross margin of -12.43, reflecting its pricing power and cost economics. The operating margin of -623.29 and net profit margin of -923.20 provide insight into operational efficiency.

Gross Margin-12.43
Operating Margin-623.29
Pretax Margin-936.45
Profit Margin-923.20
EBITDA Margin-573.04

Dividends & Yields

The company's payout ratio of 12.80 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio12.80
Shareholder Yield-422.86
FCF Yield-368.57

Scores

ENvue Medical, Inc. posts an Altman Z-Score of -30.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-30.04